Home » Depression prevention, regular check-ups, vitamin D ‘help'[클릭, 글로벌 제약.바이오]

Depression prevention, regular check-ups, vitamin D ‘help'[클릭, 글로벌 제약.바이오]

by archyde

[이데일리 유진희 기자] Global pharmaceutical and bio industry issues were collected for one week (September 19th ~ September 25th). This week, the news about depression got attention.

(Photo = Image Today)

The United States Special Committee on Disease Prevention (USPSTF) recommends that all adults be screened for depression and anxiety disorders. It is based on the results of research showing that it is effective in preventing depression and anxiety disorders.

According to Healthday News, the findings of the study were published by Dr. Elizabeth O’Connor’s research team at the Kaiser Permanent Research Center’s Evidence-based Practice Center.

The research team synthesized data from a total of 173 related research papers (a total of 8.5 million subjects). As a result, it was found that the depression test had the effect of reducing the incidence of depression or clinically significant depression after 6 to 12 months. Anxiety disorder tests also had similar effects.

However, only adults under the age of 64 (including pregnant and giving birth women) were required to take the anxiety disorder test. According to the special committee, there is insufficient evidence to judge the benefits or disadvantages of the anxiety disorder test for seniors over the age of 65.

Recommendations are posted online as draft recommendations. The final decision will be made after a public hearing by October 17th. The guidelines issued by the Special Committee are not binding. However, the USPSTF guidelines provide the basis for health insurance companies to determine the reimbursement standards for drugs or treatments.

In the meantime, studies have shown that vitamin D supplementation can help relieve depression. According to Healthday News, a research team led by Professor Tuomas Mikola from the Institute of Clinical Medicine at Eastern University of Finland has published a study showing that vitamin D supplementation is effective in relieving mild clinical depression as well as major depressive disorder (MDD).

MDD is the most common type of depression. It is diagnosed when a depressed mood, loss of interest or appetite, sleep disturbance, a feeling of worthlessness, fatigue, or suicidal thoughts persist for at least 2 weeks.

The research team comprehensively analyzed data from 41 randomized controlled clinical trials (a total of 53,235 trial participants) published so far. As a result, taking vitamin D supplements with a daily dose of 2000 IU (international unit) or less has a positive effect on alleviating depression. The neuroactive steroid and immune action of vitamin D are known to modulate the physiological mechanisms associated with depression.

The research team suggested that in order to confirm this effect of vitamin D, it is necessary to conduct a clinical trial in which vitamin D supplements are administered concurrently with the standard treatment for depression.

Vitamin D is synthesized in the body through the skin exposed to the sun’s ultraviolet rays. Sun exposure provides 90% of the vitamin D our body needs. The results of this study were published in the latest issue of ‘Critical Reviews in Food Science and Nutrition’.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.